Nada Vlaisavljević

Rituximab in the therapy of stage III and IV follicular lymphoma: Results of the REFLECT 1 study of the Serbian Lymphoma Group.

P. Djurdjevic, O. Markovic, S. Popović, 2017, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[Clinical and prognostic significance of CD34 expression in bone marrow biopsies in myelodysplastic syndrome].

A. Savic, S. Popović, V. Čemerikić-Martinović, 2010, Medicinski pregled.

Real-world evidence in diagnostics and treatment of patients with multiple myeloma

O. Markovic, I. Savić, A. Sretenović, 2022, Medical review.